bioAffinity Technologies BIAF Balance Sheet (2021-2026)

NASDAQ BIAF
$2.20 -0.14 (-5.98%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

bioAffinity Technologies Quarterly Balance Sheet

Periods 21 quarters
Latest Sep 2026

bioAffinity Technologies reported total assets of $0.01B and total liabilities of $0.00B for the quarter ended Sep 2026, down 34.6% year over year. This balance sheet covers 21 quarters of results from Sep 2021 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
1.36M13.50M11.41M9.80M8.30M4.51M2.82M2.50M0.80M0.80M1.11M0.44M0.80M7.70M6.45M3.10M2.43M2.60M
Cash & Current Investments
1.36M13.50M11.41M9.80M8.30M4.51M2.82M2.50M0.80M0.80M1.11M0.44M0.80M7.70M6.45M3.10M2.43M2.60M
Receivables - NetNet Receivables
0.00M0.01M0.01M0.01M0.09M1.11M0.81M1.12M1.60M1.33M1.14M0.96M0.42M0.45M0.54M0.69M0.89M0.74M
Receivables - OtherOther Receivables
0.01M0.00M0.03M0.06M0.12M0.05M0.03M0.02M0.02M0.03M0.03M0.03M0.02M0.02M
Receivables
0.00M0.01M0.02M0.01M0.09M1.11M0.84M1.18M1.71M1.38M1.17M0.98M0.44M0.48M0.57M0.72M0.91M0.76M
Inventory
0.01M0.01M0.01M0.01M0.01M0.02M0.01M0.03M0.03M0.03M0.04M0.04M0.04M0.05M0.08M0.08M0.11M
Prepaid Assets
0.08M0.54M0.53M0.44M0.28M0.38M0.32M0.34M0.25M0.44M0.42M0.42M0.40M0.46M0.52M0.48M0.46M0.43M
Current Assets
1.44M14.05M11.96M10.23M8.66M6.01M3.97M3.93M2.68M2.55M2.70M1.86M1.67M8.61M7.57M4.34M3.87M3.83M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
0.00M0.00M0.21M0.23M0.21M0.51M0.46M0.46M0.45M0.42M0.38M0.38M0.35M0.30M0.27M0.25M0.31M0.36M
Goodwill
1.15M1.40M1.40M1.40M1.40M1.40M1.40M1.40M1.40M1.40M1.40M1.40M1.40M
Intangibles
0.85M0.83M2.22M2.30M2.19M0.78M0.76M0.75M0.73M0.72M0.70M0.69M0.67M
Goodwill & Intangibles
2.00M2.24M3.63M3.70M3.60M2.18M2.17M2.15M2.14M2.12M2.11M2.09M2.08M
Other Non-Current Assets
0.01M0.01M0.01M0.01M0.01M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.01M0.01M0.01M0.01M0.02M0.02M
Non-Current Assets
0.02M0.01M0.22M0.23M0.21M4.18M4.25M4.12M3.98M4.00M3.82M3.68M3.08M2.93M3.40M3.60M3.75M3.73M
Assets
1.45M14.06M12.18M10.46M8.87M10.19M8.22M8.05M6.66M6.55M6.51M5.55M4.75M11.55M10.96M7.95M7.62M7.55M
Liabilities
Current Liabilities
Accounts Payables
0.23M0.15M0.35M0.15M0.17M0.83M0.60M0.38M0.85M0.78M0.99M1.38M1.17M0.94M0.76M0.84M0.97M0.95M
Notes Payables
11.15M-0.40M-1.19M0.33M16,065,332.00M-1.19M0.00M0.00M0.27M0.17M0.10M0.03M0.14M0.11M0.06M0.02M0.14M
Payables
11.38M-0.40M-1.19M0.47M16,065,332.35M0.15M-1.01M0.83M0.60M0.39M0.85M1.05M1.16M1.49M1.20M1.08M0.87M0.90M0.99M1.09M
Accumulated Expenses
1.60M0.50M0.54M0.48M0.52M0.64M1.15M0.88M0.97M0.90M1.40M1.37M1.05M0.98M1.72M2.03M1.41M1.14M
Other Accumulated Expenses
766.000.00M0.01M0.01M0.01M0.02M0.01M0.00M0.04M0.06M0.04M0.11M0.03M0.02M0.02M0.02M0.04M
Short term Debt
0.49M0.25M0.17M0.04M
Current Leases
0.36M0.37M0.37M0.38M0.39M0.40M0.40M0.18M0.12M0.14M0.08M0.08M0.08M
Current Deferred Revenue
0.04M0.04M0.03M0.03M0.03M0.02M0.02M0.02M0.02M0.04M0.04M0.03M0.03M0.05M
Total Current Liabilities
13.04M1.46M1.14M0.80M0.78M1.96M2.25M1.77M2.33M2.49M3.10M3.42M2.59M2.36M2.91M3.18M2.68M2.53M
Non-Current Liabilities
Capital Leases
0.93M0.84M0.74M0.64M0.54M0.44M0.34M0.00M0.00M0.53M0.51M0.50M0.48M
Non-Current Debt
0.16M0.02M0.02M0.02M0.02M0.05M0.05M0.04M0.04M0.04M0.04M0.03M
Convertible Debt
2.60M2.60M2.60M0.33M
Preferred Stock Liabilities
4.04M4.04M4.04M
Operating Leases
0.31M0.28M0.26M0.23M0.38M0.34M0.31M0.27M0.24M0.20M0.55M0.64M0.60M
Other Non-Current Liabilities
3.97M
Total Non-Current Liabilities
2.91M
Total Liabilities
17.24M1.46M1.14M0.80M0.78M3.20M3.37M2.79M3.22M3.43M3.91M4.11M6.89M2.64M3.68M4.30M3.85M3.64M
Shareholder's Equity
Total Debt
11.31M-0.40M-1.19M0.82M16,065,332.25M0.17M-1.14M0.03M0.03M0.29M0.19M0.15M0.08M0.18M0.15M0.10M0.06M0.18M
Common Equity
-15.79M-16.72M-16.79M12.60M11.04M9.67M8.10M6.99M4.86M5.26M3.43M3.12M2.60M1.44M-2.14M8.90M7.28M3.65M3.77M3.91M
Liabilities and Shareholders Equity
1.45M14.06M12.18M10.46M8.87M10.19M8.22M8.05M6.66M6.55M6.51M5.55M4.75M11.55M10.96M7.95M7.62M7.55M
Retained Earnings
-28.51M-35.00M-36.67M-38.20M-39.94M-42.23M-44.60M-46.60M-48.70M-50.70M-53.64M-56.30M-60.40M-65.42M-68.55M-72.20M-75.60M-80.83M
Preferred Shares
1.001.001.001.001.00

bioAffinity Technologies Balance Sheet API

Pull bioAffinity Technologies's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BIAF&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY